These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2859924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study.
    Rosenthal S, Harris DT, Horton J, Glick JH.
    Cancer Treat Rep; 1980; 64(10-11):1115-7. PubMed ID: 7459897
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Minimal single-agent activity of maytansine in refractory breast cancer: a Southwest Oncology Group study.
    Neidhart JA, Laufman LR, Vaughn C, McCracken JD.
    Cancer Treat Rep; 1980; 64(4-5):675-7. PubMed ID: 7427953
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
    O'Connell MJ, Shani A, Rubin J, Moertel CG.
    Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I trial of chlorozotocin.
    Gralla RJ, Tan CT, Young CW.
    Cancer Treat Rep; 1979 Jan; 63(1):17-20. PubMed ID: 154363
    [Abstract] [Full Text] [Related]

  • 13. Initial clinical trials of maytansine, an antitumor plant alkaloid.
    Chabner BA, Levine AS, Johnson BL, Young RC.
    Cancer Treat Rep; 1978 Mar; 62(3):429-33. PubMed ID: 348311
    [Abstract] [Full Text] [Related]

  • 14. Phase II evaluation of maytansine in patients with metastatic lung cancer.
    Eagan RT, Creagan ET, Ingle JN, Frytak S, Rubin J.
    Cancer Treat Rep; 1978 Oct; 62(10):1577-9. PubMed ID: 709559
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
    Mouridsen HT, Bramwell VH, Lacave J, Metz R, Vendrik C, Hild J, McCreanney J, Sylvester R.
    Cancer Treat Rep; 1981 Sep 15; 65(5-6):509-11. PubMed ID: 6453646
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.